NOVAREX Co.Ltd Total Assets
NOVAREX Co.Ltd total assets. Based on the latest financial reports, NOVAREX Co.Ltd (194700) holds total assets worth ₩373.19 Billion KRW (≈ $252.91 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 194700 operating cash flow for how efficiently the company converts equity into cash flow.
Total Assets of NOVAREX Co.Ltd (2015–2025)
Total assets of NOVAREX Co.Ltd from 2015 to 2025. This chart illustrates how NOVAREX Co.Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for NOVAREX Co.Ltd for real-time trading data and today's change.
NOVAREX Co.Ltd - Asset Composition Analysis
NOVAREX Co.Ltd Total Assets Breakdown (December 2025)
NOVAREX Co.Ltd total assets breakdown as of December 2025. NOVAREX Co.Ltd's total assets of ₩373.19 Billion consist of 59.2% current assets and 40.8% non-current assets. Explore 194700 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 13.8% |
| Accounts Receivable | ₩84.33 Billion | 23.5% |
| Inventory | ₩75.63 Billion | 21.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩2.17 Billion | 0.6% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how NOVAREX Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NOVAREX Co.Ltd's current assets represent 59.2% of total assets in 2025, a decrease from 69.0% in 2015.
- Cash Position: Cash and equivalents constituted 13.8% of total assets in 2025, down from 27.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 23.5% of total assets.
NOVAREX Co.Ltd Competitors by Total Assets
Key competitors of NOVAREX Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
Lotus Bakeries
BR:LOTB
|
Belgium | €1.54 Billion |
|
Conagra Brands, Inc.
NYSE:CAG
|
USA | $17.70 Billion |
|
Maple Leaf Foods Inc.
TO:MFI
|
Canada | CA$4.45 Billion |
|
By health
SHE:300146
|
China | CN¥14.00 Billion |
|
Xiamen Kingdomway Group Co
SHE:002626
|
China | CN¥8.38 Billion |
|
Nongshim
KO:004370
|
Korea | ₩4.00 Trillion |
|
Sanquan Food Co Ltd
SHE:002216
|
China | CN¥7.57 Billion |
NOVAREX Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.19 | 2.08 | 1.26 |
| Quick Ratio | 1.61 | 1.31 | 0.76 |
| Cash Ratio | 0.00 | 0.48 | 0.26 |
| Working Capital | ₩120.83 Billion | ₩82.75 Billion | ₩22.43 Billion |
NOVAREX Co.Ltd - Advanced Valuation Insights
This section examines the relationship between NOVAREX Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.90 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 24.2% |
| Total Assets | ₩359.55 Billion |
| Market Capitalization | $115.03 Million USD |
Valuation Analysis
Below Book Valuation: The market values NOVAREX Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: NOVAREX Co.Ltd's assets grew by 24.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for NOVAREX Co.Ltd (2015–2025)
The table below shows the annual total assets of NOVAREX Co.Ltd from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩359.55 Billion ≈ $243.67 Million |
+24.15% |
| 2024-12-31 | ₩289.61 Billion ≈ $196.26 Million |
+9.40% |
| 2023-12-31 | ₩264.73 Billion ≈ $179.41 Million |
-2.16% |
| 2022-12-31 | ₩270.58 Billion ≈ $183.37 Million |
+6.26% |
| 2021-12-31 | ₩254.63 Billion ≈ $172.56 Million |
+18.16% |
| 2020-12-31 | ₩215.50 Billion ≈ $146.04 Million |
+39.60% |
| 2019-12-31 | ₩154.37 Billion ≈ $104.62 Million |
+45.19% |
| 2018-12-31 | ₩106.32 Billion ≈ $72.05 Million |
+48.08% |
| 2017-12-31 | ₩71.80 Billion ≈ $48.66 Million |
+19.25% |
| 2016-12-31 | ₩60.21 Billion ≈ $40.80 Million |
+7.06% |
| 2015-12-31 | ₩56.24 Billion ≈ $38.11 Million |
-- |
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more